Dopaminergic Cell Replacement for Parkinson's Disease: Addressing the Intracranial Delivery Hurdle
Saumya Maheshwari1, Harith Akram2, Harry Bulstrode3,4
1The Medical School, University of Edinburgh, Edinburgh BioQuarter, UK.
Journal of Parkinson'S Disease
|March 8, 2024
Summary
Cell replacement therapy (CRT) offers hope for Parkinson's disease (PD) by replacing lost neurons. Optimizing neurosurgical delivery techniques is crucial for successful clinical translation and improved patient outcomes in PD treatment.
Area of Science:
- Neurology
- Neurosurgery
- Regenerative Medicine
Background:
- Parkinson's disease (PD) affects over 8.5 million worldwide, characterized by dopaminergic neuronal loss.
- Current PD treatments are largely symptomatic and do not halt disease progression.
- Cell replacement therapy (CRT) shows potential for restoring function but faces clinical challenges.
Purpose of the Study:
- To highlight key neurosurgical factors influencing the clinical translation of CRT for PD.
- To review current and future instruments for cell graft delivery.
- To discuss novel developments enhancing graft accessibility and efficacy.
Main Methods:
- Review of existing literature on neurosurgical delivery techniques for cell grafts in PD.
- Analysis of instruments used for cell graft delivery, noting features and limitations.
- Exploration of novel advancements in graft delivery and enhancement.
Main Results:
- Neurosurgical delivery factors are critical but under-studied aspects of CRT for PD.
- Existing delivery instruments have limitations that future devices aim to address.
- Novel developments may improve graft accessibility, delivery, and therapeutic efficacy.
Conclusions:
- Addressing challenges in neurosurgical delivery is essential for the success of CRT in Parkinson's disease.
- Optimized delivery strategies can significantly influence the therapeutic outcomes of cell grafts.
- Further research into neurosurgical techniques is vital to realize the full potential of CRT for PD.
Related Concept Videos
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:15Parkinson's Disease: Overview
544
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K